Clinical Trial Update: Clofarabine, Cytarabine, and Idarubicin in Treating Patients With Intermediate-Risk or High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplasia [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating a combination of clofarabine, cytarabine, and idarubicin in adults with intermediate- or high-risk acute myeloid leukemia …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Clolar (Clofarabine)
• Idamycin (idarubicin)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Leukemia, Myelodysplastic Syndromes | Phase 1, Phase 2 | Status: UNKNOWN